| Caitlin M Schmidt, DO | |
|
1105 Sixth St, Traverse City, MI 49684-2345 | |
| (231) 935-5000 | |
| Not Available |
| Full Name | Caitlin M Schmidt |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 13 Years |
| Location | 1105 Sixth St, Traverse City, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699068148 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 5101019218 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Munson Medical Center | Traverse city, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Munson Medical Center | 3072426287 | 257 |
News Archive
A new treatment for an incurable blood disorder proves a worse option for patients' health than an older treatment, according to a study to be presented today during the 46th Annual Meeting of the American Society of Hematology (ASH).
A University of Manchester spin-out company, which has created a ‘unique' optical technology for the rapid screening of eye diseases in a bid to improve the health of a growing and ageing population, is raising finance for the market launch of its first product and to support its R&D activities in ophthalmology diagnostics.
Morphotek, Inc. announced today that it has commenced a multi-center, Phase II study evaluating the safety and efficacy of MORAb-004 when combined with gemcitabine and docetaxel in the treatment of metastatic soft tissue sarcoma.
Alzheimer's disease has long been studied primarily as a disease of neurons. But researchers have now shown how the disease may be damaging the brain by choking off blood flow. In experiments published June 10 in Neuron, scientists at Rockefeller University reveal that amyloid-β, which builds up around brain cells in Alzheimer's patients, interacts with a common blood clotting agent to increase clotting in the arteries that feed the brain.
Black prostate cancer patients may not be getting the same quality of care as white patients, according to a first-of-its-kind study by researchers at Henry Ford Hospital who found racial disparities in the results of surgery to remove diseased prostates.
› Verified 1 days ago
| Entity Name | Edward W Sparrow Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831139088 PECOS PAC ID: 6709799166 Enrollment ID: O20040102000790 |
News Archive
A new treatment for an incurable blood disorder proves a worse option for patients' health than an older treatment, according to a study to be presented today during the 46th Annual Meeting of the American Society of Hematology (ASH).
A University of Manchester spin-out company, which has created a ‘unique' optical technology for the rapid screening of eye diseases in a bid to improve the health of a growing and ageing population, is raising finance for the market launch of its first product and to support its R&D activities in ophthalmology diagnostics.
Morphotek, Inc. announced today that it has commenced a multi-center, Phase II study evaluating the safety and efficacy of MORAb-004 when combined with gemcitabine and docetaxel in the treatment of metastatic soft tissue sarcoma.
Alzheimer's disease has long been studied primarily as a disease of neurons. But researchers have now shown how the disease may be damaging the brain by choking off blood flow. In experiments published June 10 in Neuron, scientists at Rockefeller University reveal that amyloid-β, which builds up around brain cells in Alzheimer's patients, interacts with a common blood clotting agent to increase clotting in the arteries that feed the brain.
Black prostate cancer patients may not be getting the same quality of care as white patients, according to a first-of-its-kind study by researchers at Henry Ford Hospital who found racial disparities in the results of surgery to remove diseased prostates.
› Verified 1 days ago
| Entity Name | Munson Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083761860 PECOS PAC ID: 3072426287 Enrollment ID: O20040108000904 |
News Archive
A new treatment for an incurable blood disorder proves a worse option for patients' health than an older treatment, according to a study to be presented today during the 46th Annual Meeting of the American Society of Hematology (ASH).
A University of Manchester spin-out company, which has created a ‘unique' optical technology for the rapid screening of eye diseases in a bid to improve the health of a growing and ageing population, is raising finance for the market launch of its first product and to support its R&D activities in ophthalmology diagnostics.
Morphotek, Inc. announced today that it has commenced a multi-center, Phase II study evaluating the safety and efficacy of MORAb-004 when combined with gemcitabine and docetaxel in the treatment of metastatic soft tissue sarcoma.
Alzheimer's disease has long been studied primarily as a disease of neurons. But researchers have now shown how the disease may be damaging the brain by choking off blood flow. In experiments published June 10 in Neuron, scientists at Rockefeller University reveal that amyloid-β, which builds up around brain cells in Alzheimer's patients, interacts with a common blood clotting agent to increase clotting in the arteries that feed the brain.
Black prostate cancer patients may not be getting the same quality of care as white patients, according to a first-of-its-kind study by researchers at Henry Ford Hospital who found racial disparities in the results of surgery to remove diseased prostates.
› Verified 1 days ago
| Entity Name | Noch Physician Billing Company Llc |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1972550580 PECOS PAC ID: 8527078583 Enrollment ID: O20140401000168 |
News Archive
A new treatment for an incurable blood disorder proves a worse option for patients' health than an older treatment, according to a study to be presented today during the 46th Annual Meeting of the American Society of Hematology (ASH).
A University of Manchester spin-out company, which has created a ‘unique' optical technology for the rapid screening of eye diseases in a bid to improve the health of a growing and ageing population, is raising finance for the market launch of its first product and to support its R&D activities in ophthalmology diagnostics.
Morphotek, Inc. announced today that it has commenced a multi-center, Phase II study evaluating the safety and efficacy of MORAb-004 when combined with gemcitabine and docetaxel in the treatment of metastatic soft tissue sarcoma.
Alzheimer's disease has long been studied primarily as a disease of neurons. But researchers have now shown how the disease may be damaging the brain by choking off blood flow. In experiments published June 10 in Neuron, scientists at Rockefeller University reveal that amyloid-β, which builds up around brain cells in Alzheimer's patients, interacts with a common blood clotting agent to increase clotting in the arteries that feed the brain.
Black prostate cancer patients may not be getting the same quality of care as white patients, according to a first-of-its-kind study by researchers at Henry Ford Hospital who found racial disparities in the results of surgery to remove diseased prostates.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Caitlin M Schmidt, DO 1310 Wisconsin Ave, Suite 101, Grand Haven, MI 49417-2472 Ph: (616) 844-4528 | Caitlin M Schmidt, DO 1105 Sixth St, Traverse City, MI 49684-2345 Ph: (231) 935-5000 |
News Archive
A new treatment for an incurable blood disorder proves a worse option for patients' health than an older treatment, according to a study to be presented today during the 46th Annual Meeting of the American Society of Hematology (ASH).
A University of Manchester spin-out company, which has created a ‘unique' optical technology for the rapid screening of eye diseases in a bid to improve the health of a growing and ageing population, is raising finance for the market launch of its first product and to support its R&D activities in ophthalmology diagnostics.
Morphotek, Inc. announced today that it has commenced a multi-center, Phase II study evaluating the safety and efficacy of MORAb-004 when combined with gemcitabine and docetaxel in the treatment of metastatic soft tissue sarcoma.
Alzheimer's disease has long been studied primarily as a disease of neurons. But researchers have now shown how the disease may be damaging the brain by choking off blood flow. In experiments published June 10 in Neuron, scientists at Rockefeller University reveal that amyloid-β, which builds up around brain cells in Alzheimer's patients, interacts with a common blood clotting agent to increase clotting in the arteries that feed the brain.
Black prostate cancer patients may not be getting the same quality of care as white patients, according to a first-of-its-kind study by researchers at Henry Ford Hospital who found racial disparities in the results of surgery to remove diseased prostates.
› Verified 1 days ago
Diana Lynn Novak, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3960 W Royal Dr, Traverse City, MI 49684 Phone: 231-947-0404 Fax: 231-947-2190 | |
Dr. Laura J Danz, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1200 6th St, Ste 400, Traverse City, MI 49684 Phone: 231-392-0650 Fax: 231-392-0665 | |
Dr. Jennie Rose, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 4400 Lands End, Traverse City, MI 49686 Phone: 231-944-4171 | |
Debra Joan Kurtz, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1200 Sixth St, Ste 400, Traverse City, MI 49684 Phone: 231-392-0655 Fax: 231-392-0665 | |
Dr. Don A Good, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1200 6th St, Ste 400, Traverse City, MI 49684 Phone: 231-392-0650 Fax: 231-392-0665 | |
Dr. Douglas L Mckay, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1200 6th St, Ste 400, Traverse City, MI 49684 Phone: 231-392-0650 Fax: 231-392-0665 | |
Dr. Marcy Verplanck-kanitz, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1200 6th St, Ste 400, Traverse City, MI 49684 Phone: 231-392-0650 Fax: 231-392-0665 |